FOSCARNET SODIUM
Generic: FOSCARNET SODIUM
Caplin Steriles LimitedManufacturer
INTRAVENOUSRoute
FOSCARNET SODIUMActive Substance
2026-05-13Original Approval
FOSCARNET SODIUM is FDA application ANDA220068, sponsored by CAPLIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
284 reports
2
DRUG INEFFECTIVE
150 reports
3
ACUTE KIDNEY INJURY
143 reports
4
PANCYTOPENIA
114 reports
5
DRUG RESISTANCE
100 reports
6
CYTOMEGALOVIRUS INFECTION
93 reports
7
NEPHROPATHY TOXIC
88 reports
8
BK VIRUS INFECTION
80 reports
9
CYTOMEGALOVIRUS INFECTION REACTIVATION
80 reports
10
CYSTITIS HAEMORRHAGIC
78 reports